Post-Infectious IBS: How Food Poisoning and GI Infections May Trigger IBS
Many people with post-infectious IBS (PI-IBS) can actually pinpoint exactly when their symptoms began.
Unlike other forms of irritable bowel syndrome that may develop gradually over time, post-infectious IBS often develops after a gastrointestinal infection and may persist long after the original illness resolves.
Post-infectious IBS (PI-IBS) is defined as an IBS diagnosis that develops in the months following infectious enteritis in individuals who did not previously have IBS symptoms.
Infections Associated with PI-IBS
Several types of gastrointestinal infections have been linked to post-infectious IBS, including bacterial, viral, and parasitic infections.
Examples include:
- Salmonella
- Campylobacter jejuni
- Norwalk virus
- Giardia duodenalis (also called Giardia lamblia)
These infections are commonly associated with foodborne illness or contaminated food and water exposure. In some cases, infections may also occur while traveling internationally, particularly in regions where the risk of foodborne or waterborne illness is higher.
In fact, PI-IBS is considered one of the more frequently diagnosed conditions in post-travel clinics.
How Common Is Post-Infectious IBS?
Research suggests that approximately 1 in 10 individuals who experience infectious enteritis may later develop PI-IBS. However, the exact risk appears to vary depending on the severity of the infection and individual risk factors.
- Female sex
- Younger age
- Antibiotic use
- History of anxiety or depression
- Parasitic infections
- Possible genetic predisposition
Interestingly, parasitic infections appear more likely to lead to PI-IBS than bacterial infections, while viral infections may carry a comparatively lower risk.
Why Do Some People Develop PI-IBS?
Researchers still do not fully understand why some individuals develop IBS after infection while others recover completely.
- Excessive inflammation within the gastrointestinal tract
- Altered gut-brain signaling
- Changes in the gut microbiome and loss of beneficial bacteria
These changes may persist even after the original infection has resolved, potentially contributing to ongoing digestive symptoms.
More recent research suggests the picture may be even more complex, involving immune activation, intestinal permeability, nervous system signaling, and microbiome alterations working together.
What Happens After Diagnosis?
Most cases of PI-IBS tend to resemble diarrhea-predominant IBS (IBS-D), and treatment approaches are often based on symptom presentation.
Management may include:
- Dietary interventions
- Stress management
- Medication when appropriate
- Gut-directed therapies
- Individualized nutrition support
One encouraging aspect of PI-IBS is that symptoms often improve gradually over time. Research suggests that many individuals experience symptom improvement over several years, meaning the long-term outlook is often more positive than it may initially seem.
Are There Specific Treatments for PI-IBS?
At this time, there are no treatment guidelines specifically unique to PI-IBS.
A 2015 systematic review and meta-analysis found limited evidence supporting any one pharmacological treatment as clearly superior for PI-IBS specifically.
As a result, treatment strategies are typically individualized based on symptoms and overall digestive health goals.
Emerging Research: Glutamine and PI-IBS
One emerging area of interest involves glutamine supplementation.
Glutamine is an amino acid naturally found in various foods and within the body itself. Researchers have explored glutamine’s potential role in:
- Supporting intestinal barrier integrity
- Maintaining gut lining health
- Supporting the microbiome
- Reducing intestinal inflammation
A 2021 study published in Frontiers in Nutrition found that glutamine supplementation combined with a Low FODMAP diet improved IBS symptoms in some individuals.
Several years earlier, a study published in Gut specifically evaluated glutamine supplementation in individuals with PI-IBS. Researchers found that taking 5 grams of glutamine twice daily for 8 weeks reduced the severity of IBS symptoms compared with a placebo.
While research in this area remains limited, these findings offer interesting insight into possible future directions for managing this unique and often understudied subtype of IBS.
Final Thoughts
Post-infectious IBS is a distinct form of IBS that develops after gastrointestinal infection, often following food poisoning or infectious enteritis.
Although researchers are still working to fully understand why PI-IBS develops, inflammation, microbiome disruption, and altered gut-brain signaling all appear to play important roles.
The good news is that many individuals gradually improve over time, and ongoing research continues exploring new management approaches—including the possible role of glutamine and microbiome-focused therapies.
As always, individuals experiencing persistent digestive symptoms after gastrointestinal illness should speak with a healthcare provider or Registered Dietitian Nutritionist (RDN) for individualized support and evaluation.
- Barbara, G., Grover, M., Bercik, P., Corsetti, M., Ghoshal, U. C., Ohman, L., Rajilić-Stojanović, M., Quigley, E. M. M., Colomier, E., & Vanner, S. J. (2021). Rome Foundation working team report on post-infection irritable bowel syndrome. Gastroenterology, 160(1), 46–58.e7. https://doi.org/10.1053/j.gastro.2020.06.088
- Futagami, S., Itoh, T., & Sakamoto, C. (2015). Systematic review with meta-analysis: Post-infectious irritable bowel syndrome after traveller’s diarrhoea. Tropical Diseases, Travel Medicine and Vaccines, 1(1), 14. https://doi.org/10.1186/s40794-015-0015-3
- Klem, F., Wadhwa, A., Prokop, L. J., Sundt, W. J., Farrugia, G., Camilleri, M., Singh, S., & Grover, M. (2017). Prevalence, risk factors, and outcomes of irritable bowel syndrome after infectious enteritis: A systematic review and meta-analysis. Gastroenterology, 152(5), 1042–1054.e1. https://doi.org/10.1053/j.gastro.2016.12.039
- Pike, B. L., Porter, C. K., & Riddle, M. S. (2013). Post-infectious irritable bowel syndrome: A review of the literature. Current Gastroenterology Reports, 15(7), 343. https://doi.org/10.1007/s11894-013-0343-1
- Schmulson, M., & Chey, W. D. (2012). IBS and other functional bowel disorders. Gastroenterology Clinics of North America, 41(2), 247–262. https://doi.org/10.1016/j.gtc.2012.01.005
- Spiller, R., & Garsed, K. (2009). Postinfectious irritable bowel syndrome. Gastroenterology, 136(6), 1979–1988. https://doi.org/10.1053/j.gastro.2009.02.074
- Zhou, Q., Verne, M. L., Fields, J. Z., Lefante, J. J., Basra, S., Salameh, H., & Verne, G. N. (2019). Randomised placebo-controlled trial of dietary glutamine supplements for postinfectious irritable bowel syndrome. Gut, 68(6), 996–1002. https://doi.org/10.1136/gutjnl-2017-315136
- Zhou, Q., Yang, M., & Verne, G. N. (2021). Glutamine supplementation combined with low FODMAP diet improves IBS symptoms: Emerging evidence and mechanisms. Frontiers in Nutrition, 8, 746703. https://doi.org/10.3389/fnut.2021.746703
Recipes
Products
Comments
Join The Conversation...